Opening book details…
About this Medicine article
345 Phase 3 study of combination pembrolizumab + olaparib therapy versus enzalutamide/abiraterone in metastatic castration-resistant prostate cancer (mCRPC) after progression on chemotherapy (KEYLYNK-010) by Yu, Evan ;Park, Se Hoon ;Huang, Yi-Hsiu ;Bennamoun, Mostefa ;Xu, Lu ;Kim, Jeri ;Antonarakis, Emmanuel is a Medicine article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- Yu, Evan ;Park, Se Hoon ;Huang, Yi-Hsiu ;Bennamoun, Mostefa ;Xu, Lu ;Kim, Jeri ;Antonarakis, Emmanuel
- Publisher
- BMJ
- Published
- 2020
- Field
- Medicine (Health Sciences)